Table 3.
6-month of follow-up | 12-month of follow-up | |||||||
---|---|---|---|---|---|---|---|---|
UC | TBC | *Δ [95% CI] | *p-value | UC | TBC | *Δ [95% CI] | *p-value | |
n = 42 | n = 39 | n = 41 | n = 35 | |||||
Mean systolic ABPM, mmHg (SD) | 140 (17) | 137 (17) | −3 [-10 to +4] | 0.45 | 141 (14) | 134 (14) | −7 [-13 to−2] | 0.01 |
Mean diastolic ABPM, mmHg (SD) | 83 (8) | 85 (9) | 2 [-1 to +6] | 0.20 | 84 (10) | 81 (8) | −2 [-5 to +2] | 0.42 |
Systolic ABPM <135 mmHg, n (%) | 39% | 42% | 0.63 | 26% | 44% | 0.07 | ||
Diastolic ABPM <85 mmHg, n (%) | 52% | 48% | 0.45 | 48% | 53% | 0.33 |
The mean between group difference (Δ) and related statistical significance are computed following the intention-to-treat principle (ITT).
UC, usual care; TBC, team-based care; SD, standard deviation; CI, confidence interval.